Cephalon
Malvern · Founded 1987
About Cephalon
Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries.
Company Facts
- Founded: 1987
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Ticker: nasdaq:CEPH
- Website: cephalon.com
- Phone: 610-344-0200
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cephalon-2710267 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.